Navigation Links
Cholesterol Drugs May Slow MS
Date:4/16/2010

Fewer brain lesions developed in patients taking Lipitor than placebo, researchers say

FRIDAY, April 16 (HealthDay News) -- Cholesterol-lowering statin drugs may slow the progression of multiple sclerosis, according to a new study.

It included 81 patients with early-stage MS randomly selected to take either 80 milligrams a day of Lipitor (atorvastatin) or a placebo. After 12 months of treatment, 55.3 percent of patients taking the drug had developed no new brain lesions, compared with 27.6 percent of those who took the placebo.

The results of the phase II, multi-center trial were presented Wednesday at the annual scientific meeting of the American Academy of Neurology. Lipitor, placebo and additional support were provided by Pfizer, Inc., which makes Lipitor.

"Our data is preliminary, and we need a larger study to confirm the effects of the drug and their magnitude," study co-leader Dr. Emmanuelle Waubant, an associate professor of neurology at the MS Center at the University of California, San Francisco, said in a news release.

"It is important that we understand how statins impact the progression of multiple sclerosis in order to better inform physicians and patients of their effect since these drugs are so broadly used throughout the United States and the world, and to learn whether a relatively inexpensive oral therapy can slow the course of the disease," he added.

MS is an autoimmune disease in which immune cells attack the central nervous system and destroy the protective sheath (myelin) that surrounds nerves. This results in scars or lesions in demyelinated areas of the brain and spinal cord.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about multiple sclerosis.



-- Robert Preidt



SOURCE: University of California, San Francisco, news release, April 14, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Menopause Often Means Worsening Cholesterol
2. QuickMedial Praises New Study Linking High Cholesterol Levels to Increased Risk for Developing Alzheimer's Disease or Vascular Dementia
3. Cholesterol-Lowering Drug Shows Promise Against Serious Infections in Sickle Cell Disease
4. Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD
5. Normal Cholesterol Doesnt Guarantee Healthy Heart
6. Low cholesterol transfer protein activity associated with heart disease risk
7. Latest epidemic? High cholesterol, obesity in fruit flies
8. Myrrh May Lower High Cholesterol
9. Eating Your Way to Low Cholesterol: How I Lowered My Cholesterol Without Drugs
10. A common cholesterol drug fights cataracts, too
11. Teamwork Unlikely to Improve Cholesterol Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2017)... Petersburg, Florida (PRWEB) , ... January 14, 2017 , ... ... Emoji Scale. , The Emoji Scale is now available on Apple as a ... give emoji ratings simply by choosing one of the ten color coded values on ...
(Date:1/13/2017)... (PRWEB) , ... January 13, 2017 , ... KOAMTAC ... companions, will be showcasing the next generation companion scanner and data collector at the ... new KDC270 has been created as an answer to the market’s need for more ...
(Date:1/13/2017)... ... January 13, 2017 , ... "We wanted to create a design for orthodontic ... two inventors from Virginia Beach, Va. , They created a prototype for the patent-pending ... accessories allow braces to be customized to suit personal tastes. They can be used ...
(Date:1/13/2017)... ... 13, 2017 , ... As the nation watches this month’s transition to a ... schools of education across the country is urging a fundamental reconsideration of the problems ... today, 175 deans sounded the alarm: “Our children suffer when we deny that educational ...
(Date:1/13/2017)... ... January 13, 2017 , ... Dr. Les Latner, owner ... a fundraising campaign for the American Academy of Cosmetic Dentistry Charitable Foundation (AACDCF) ... in rebuilding the smiles and lives of adults who have suffered dental injuries ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... , January 13, 2017 ... "Transfection Reagents and Equipment Market by Method (Biochemical ... Application (Biomedical, Protein Production), End User - Global ... studies the global market from 2016 to 2021. ... Billion by 2021 from USD 715.4 Million in ...
(Date:1/13/2017)... 2017 The 2016 election resulted in ... states voting in favor of legalizing cannabis for recreational use, ... in the U.S. In addition, the state of ... cannabis products sales. The ArcView Group has published an updated ... cannabis sales in the U.S. last year reached $6.7 billion, a ...
(Date:1/13/2017)... Jan. 12, 2017  Rosen Law Firm, a global ... class action lawsuit on behalf of purchasers of Alexion ... February 10, 2014 through November 9, 2016, inclusive (the ... Alexion investors under the federal securities laws. ... http://rosenlegal.com/cases-991.html or call Phillip Kim, Esq. ...
Breaking Medicine Technology: